TG Therapeutics (TGTX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports ...

A TG Therapeutics multiple sclerosis drug that’s new to the U.S. market will be commercialized in Europe and other regions under a partnership that pays the biotech $140 million up front. According to ...

TG Therapeutics refinanced an old $250 million facility and drew a new five-year, $750 million term loan. They drew upon the ...

TG Therapeutics is winding down its oncology program after removing the FDA-approved cancer med Ukoniq from the market in two indications that were granted accelerated approval in addition to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...